🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioNTech SE (BVMF:B1NT34)
Brazil flag Brazil · Delayed Price · Currency is BRL
30.61
-0.43 (-1.39%)
At close: Nov 17, 2026

BioNTech SE Statistics

Total Valuation

BioNTech SE has a market cap or net worth of BRL 121.69 billion. The enterprise value is 34.09 billion.

Market Cap121.69B
Enterprise Value 34.09B

Important Dates

The last earnings date was Tuesday, November 3, 2026.

Earnings Date Nov 3, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +4.29%
Shares Change (QoQ) -0.23%
Owned by Insiders (%) 16.22%
Owned by Institutions (%) 21.00%
Float 106.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.60
PB Ratio 1.17
P/TBV Ratio 1.29
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.19
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.55, with a Debt / Equity ratio of 0.02.

Current Ratio 8.55
Quick Ratio 7.91
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -92.55

Financial Efficiency

Return on equity (ROE) is -8.14% and return on invested capital (ROIC) is -29.88%.

Return on Equity (ROE) -8.14%
Return on Assets (ROA) -4.04%
Return on Invested Capital (ROIC) -29.88%
Return on Capital Employed (ROCE) -7.32%
Weighted Average Cost of Capital (WACC) 11.43%
Revenue Per Employee 1.82M
Profits Per Employee -1.11M
Employee Count7,807
Asset Turnover 0.12
Inventory Turnover 3.88

Taxes

In the past 12 months, BioNTech SE has paid 241.17 million in taxes.

Income Tax 241.17M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -10.50% in the last 52 weeks. The beta is 1.33, so BioNTech SE's price volatility has been higher than the market average.

Beta (5Y) 1.33
52-Week Price Change -10.50%
50-Day Moving Average 30.45
200-Day Moving Average 31.09
Relative Strength Index (RSI) 53.73
Average Volume (20 Days) 1,361

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 1.80

Income Statement

In the last 12 months, BioNTech SE had revenue of BRL 14.24 billion and -8.67 billion in losses. Loss per share was -2.42.

Revenue14.24B
Gross Profit 10.92B
Operating Income -7.89B
Pretax Income -8.42B
Net Income -8.67B
EBITDA -5.98B
EBIT -7.89B
Loss Per Share -2.42
Full Income Statement

Balance Sheet

The company has 80.57 billion in cash and 2.12 billion in debt, with a net cash position of 78.45 billion.

Cash & Cash Equivalents 80.57B
Total Debt 2.12B
Net Cash 78.45B
Net Cash Per Share n/a
Equity (Book Value) 104.18B
Book Value Per Share 26.26
Working Capital 81.42B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.36 billion and capital expenditures -1.22 billion, giving a free cash flow of -2.58 billion.

Operating Cash Flow -1.36B
Capital Expenditures -1.22B
Depreciation & Amortization 2.07B
Net Borrowing 485.41M
Free Cash Flow -2.58B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 76.73%, with operating and profit margins of -55.45% and -60.87%.

Gross Margin 76.73%
Operating Margin -55.45%
Pretax Margin -59.17%
Profit Margin -60.87%
EBITDA Margin -41.99%
EBIT Margin -55.45%
FCF Margin n/a

Dividends & Yields

BioNTech SE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -4.29%
Shareholder Yield -4.29%
Earnings Yield -7.85%
FCF Yield -2.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 2.

Last Split Date Nov 21, 2022
Split Type Forward
Split Ratio 2

Scores

BioNTech SE has an Altman Z-Score of 7.02 and a Piotroski F-Score of 2.

Altman Z-Score 7.02
Piotroski F-Score 2